This paper is in the following e-collection/theme issue:

COVID-19 Vaccination (126) Outbreak and Pandemic Preparedness and Management (1673) Infectious Diseases (non-STD/STI) (1478) Secondary Use of Clinical Data for Research and Surveillance (317) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1301) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1481) Stroke (147) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (143)

Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/53807, first published .
Ischemic Stroke After Bivalent COVID-19 Vaccination: Self-Controlled Case Series Study

Ischemic Stroke After Bivalent COVID-19 Vaccination: Self-Controlled Case Series Study

Ischemic Stroke After Bivalent COVID-19 Vaccination: Self-Controlled Case Series Study

Authors of this article:

Stanley Xu1 Author Orcid Image ;   Lina S Sy1 Author Orcid Image ;   Vennis Hong1 Author Orcid Image ;   Kimberly J Holmquist1 Author Orcid Image ;   Lei Qian1 Author Orcid Image ;   Paddy Farrington2 Author Orcid Image ;   Katia J Bruxvoort3 Author Orcid Image ;   Nicola P Klein4 Author Orcid Image ;   Bruce Fireman4 Author Orcid Image ;   Bing Han1 Author Orcid Image ;   Bruno J Lewin1 Author Orcid Image
Article Authors Cited by Tweetations (10) Metrics

Stanley Xu   1 , PhD ;   Lina S Sy   1 , MPH ;   Vennis Hong   1 , MPH ;   Kimberly J Holmquist   1 , MPH ;   Lei Qian   1 , PhD ;   Paddy Farrington   2 , PhD ;   Katia J Bruxvoort   3 , PhD ;   Nicola P Klein   4 , MD ;   Bruce Fireman   4 , MS ;   Bing Han   1 , PhD ;   Bruno J Lewin   1 , MD

1 Department of Research & Evaluation, Southern California Permanente Medical Group, Pasadena, CA, United States

2 School of Mathematics and Statistics, The Open University, United Kingdom

3 Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States

4 Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, CA, United States

Corresponding Author:

  • Stanley Xu, PhD
  • Department of Research & Evaluation
  • Southern California Permanente Medical Group
  • 100 S Los Robles
  • Pasadena, CA, 91101
  • United States
  • Phone: 1 6265643958
  • Email: stan.xu@kp.org